Avantax Planning Partners Inc. Has $549,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Avantax Planning Partners Inc. raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,051 shares of the medical equipment provider’s stock after buying an additional 89 shares during the period. Avantax Planning Partners Inc.’s holdings in Intuitive Surgical were worth $549,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the business. Miller Financial Services LLC bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $700,000. King Luther Capital Management Corp boosted its stake in shares of Intuitive Surgical by 4.3% during the 4th quarter. King Luther Capital Management Corp now owns 5,907 shares of the medical equipment provider’s stock worth $3,083,000 after acquiring an additional 242 shares during the last quarter. Morling Financial Advisors LLC lifted its stake in shares of Intuitive Surgical by 6.5% during the 4th quarter. Morling Financial Advisors LLC now owns 660 shares of the medical equipment provider’s stock valued at $344,000 after buying an additional 40 shares in the last quarter. Citizens Financial Group Inc. RI lifted its stake in Intuitive Surgical by 19.1% in the 4th quarter. Citizens Financial Group Inc. RI now owns 9,669 shares of the medical equipment provider’s stock worth $5,047,000 after purchasing an additional 1,549 shares in the last quarter. Finally, Sage Mountain Advisors LLC grew its holdings in Intuitive Surgical by 1.4% during the 4th quarter. Sage Mountain Advisors LLC now owns 1,869 shares of the medical equipment provider’s stock valued at $976,000 after purchasing an additional 25 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, SVP Mark Brosius sold 489 shares of the firm’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $533.18, for a total value of $260,725.02. Following the sale, the senior vice president now directly owns 2,091 shares in the company, valued at approximately $1,114,879.38. This trade represents a 18.95 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,309 shares of company stock worth $7,611,004 in the last 90 days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG opened at $493.72 on Wednesday. The firm has a market capitalization of $175.85 billion, a PE ratio of 77.02, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The company’s fifty day moving average price is $569.91 and its 200-day moving average price is $531.84. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. CICC Research began coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 target price for the company. Barclays raised their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Piper Sandler restated an “overweight” rating and issued a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Raymond James boosted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Finally, Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.